Alcon, officially known as Alcon Inc., is a global leader in eye care, headquartered in Switzerland (CH). Founded in 1945, the company has established a strong presence in major operational regions, including North America, Europe, and Asia. Alcon is renowned for its innovative products in the ophthalmic industry, focusing on surgical and vision care solutions. The company’s core offerings include advanced surgical equipment, contact lenses, and eye care products, distinguished by their cutting-edge technology and commitment to improving patient outcomes. Alcon's dedication to research and development has positioned it as a market leader, with notable achievements in enhancing vision correction and surgical precision. With a rich history and a focus on innovation, Alcon continues to shape the future of eye care globally.
How does Alcon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Alcon's score of 46 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Alcon reported total greenhouse gas emissions of approximately 204,978,000 kg CO2e, comprising 74,202,000 kg CO2e from Scope 1 and 130,776,000 kg CO2e from Scope 2 emissions. This marks a slight decrease from 2023, where total emissions were about 233,482,000 kg CO2e, with Scope 1 emissions at 75,183,000 kg CO2e and Scope 2 emissions at 158,299,000 kg CO2e. Alcon has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. The company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, which may limit its ability to demonstrate a proactive approach to climate commitments. The emissions data is sourced directly from Alcon Inc., with no cascaded data from a parent or related organization. Alcon's headquarters is located in Switzerland (CH), and the company continues to focus on sustainability within the medical device industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | - | - | - | - | - | - | - | - | - | - | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alcon has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
